Technologies Inc. (NYSE: A) today announced that it will host the
western regional conference of the National Academy of Engineering,
along with a technical symposium—Bioengineering, Advancing Our World—at
company headquarters in Santa Clara, California, on March 28, 2019.
Open to the public, the symposium will be led by Darlene Solomon,
Agilent senior vice president, and chief technology officer. It will
feature four of bioengineering’s leading innovators, who will highlight
their research in precision medicine, biomaterials for drug delivery,
cellular manufacturing, and biological systems.
Steve Quake is the Lee Otterson Professor of Bioengineering,
co-president of the Chan-Zuckerberg Biohub, and a professor of applied
physics at Stanford University. Quake’s interests lie at the nexus of
physics, biology, and biotechnology. His research is concerned with
developing new approaches to biological measurement and applying them to
problems of both fundamental and medical interest.
Tejal Desai is the Ernest L. Prien Professor and chair of the department
of bioengineering and therapeutic sciences for the University of
California, San Francisco. Her research brings together advanced micro
and nanotechnologies, fundamental insights into cellular behavior in
engineered environments, and novel pharmacologic delivery approaches.
Jay Keasling is a professor of chemical engineering and bioengineering
with the University of California, Berkeley. He is also chief science
and technology officer for biosciences at the Lawrence Berkeley National
Laboratory, and chief executive of the Joint BioEnergy Institute. His
interdisciplinary team of scientists and engineers focuses on
engineering the chemistry inside microbial cells to produce lifesaving
therapies, clean-burning fuels, and new materials for a variety of
Karl Deisseroth is the D.H. Chen Professor of Bioengineering, as well as
a professor of psychiatry and behavioral sciences at Stanford
University. His lab develops and applies tools for controlling and
mapping specific elements within intact biological systems.
“Our ability to measure, understand, and apply biology is advancing
rapidly, enabling transformational improvement to the human condition;
this is Agilent’s mission, and we are delighted to see today’s terrific
participation,” said Solomon. “I’m grateful to NAE and our extraordinary
speakers for their contributions to this exciting symposium for our
Greater Bay Area technical community.”
“Everyone attending the Regional Meeting is deeply appreciative of the
contributions of the distinguished speakers, and of Agilent too, that
make this meeting so exceptional,“ said C. D. Mote Jr., president of the
National Academy of Engineering. “I never get over how generous, so many
contributors are with their time, talents, and facilities, which when
taken together are the academy’s value to society. I appreciate
Agilent’s willingness to host the meeting, and for doing it so well.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics and applied chemical markets. With more than 50 years of
insight and innovation, Agilent instruments, software, services,
solutions, and people provide trusted answers to customers’ most
challenging questions. The company generated revenues of $4.91 billion
in fiscal 2018 and employs 15,300 people worldwide. Information about
Agilent is available at www.agilent.com.
To receive the latest Agilent news, subscribe to our Newsroom.
Follow Agilent on LinkedIn,